Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.250
-1.800 (-44.44%)
At close: Dec 18, 2025, 4:00 PM EST
2.310
+0.060 (2.67%)
After-hours: Dec 18, 2025, 5:59 PM EST
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $86.54 million as of December 18, 2025. Its market cap has increased by 86.43% in one year.
Market Cap
86.54M
Enterprise Value
97.95M
1-Year Change
86.43%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $86.54M, a decrease of -30.57%. That is a compound annual growth rate of -7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 155.77M | 171.88% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |